Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.

已完结 10 由得得七七发布于 2025/7/6 21:51:23

DOI:10.1056/nejmoa2415820
作者：Stephen J Nicholls,Adam J Nelson,Marc Ditmarsch,John J P Kastelein,Christie M Ballantyne,Kausik K Ray,Ann Marie Navar,Steven E Nissen,Mariko Harada-Shiba,Danielle L Curcio,Annie Neild,Douglas Kling,An
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：BACKGROUND Obicetrapib is a highly selective cholesteryl ester transfer protein inhibitor that reduces low-density lipoprotein (LDL) cholesterol levels. The efficacy and safety of obicetrap

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierFixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial